Tami Tillotson Martin

VP of Regulatory Affairs, SUPERNUS PHARMACEUTICALS, INC.

Companies

SUPERNUS PHARMACEUTICALS, INC.VP of Regulatory Affairs Apr 30, 2012 to Feb 27, 2024¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 23, 2024Shares withheld for tax 485 shares at $29.06 of SUPERNUS PHARMACEUTICALS, INC.²
Feb 23, 2024Granted 1,250 shares of SUPERNUS PHARMACEUTICALS, INC.²
Feb 22, 2024Shares withheld for tax 246 shares at $27.94 of SUPERNUS PHARMACEUTICALS, INC.³
Feb 22, 2024Granted 750 shares of SUPERNUS PHARMACEUTICALS, INC.³
Jan 10, 2024Sold 8,000 shares at $27.91 of SUPERNUS PHARMACEUTICALS, INC.⁴
Jan 10, 2024Exercised options 8,000 shares at $9.24 of SUPERNUS PHARMACEUTICALS, INC.⁴
Aug 30, 2023Sold 8,100 shares at $32.00 of SUPERNUS PHARMACEUTICALS, INC.⁵
Aug 30, 2023Exercised options 8,100 shares at $23.99 of SUPERNUS PHARMACEUTICALS, INC.⁵
Aug 25, 2023Sold 5,135 shares at $31.59 of SUPERNUS PHARMACEUTICALS, INC.⁶
Feb 22, 2023Shares withheld for tax 289 shares at $38.57 of SUPERNUS PHARMACEUTICALS, INC.⁷
Feb 22, 2023Granted 750 shares of SUPERNUS PHARMACEUTICALS, INC.⁸
Feb 22, 2023Granted 750 shares of SUPERNUS PHARMACEUTICALS, INC.⁷
Feb 16, 2023Exercised options 1,500 shares of SUPERNUS PHARMACEUTICALS, INC.⁹
Aug 22, 2022Sold 5,000 shares at $35.98 of SUPERNUS PHARMACEUTICALS, INC.¹⁰
Aug 22, 2022Exercised options 5,000 shares at $7.90 of SUPERNUS PHARMACEUTICALS, INC.¹⁰
Aug 4, 2022Sold 5,000 shares at $32.98 of SUPERNUS PHARMACEUTICALS, INC.¹¹
Aug 4, 2022Exercised options 5,000 shares at $7.90 of SUPERNUS PHARMACEUTICALS, INC.¹¹

The numbers on this page point here. Each one links to the record it came from.